S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism-Reference-Cited by-同舟云学术

S62798, a potent TAFIa inhibitor, accelerates endogenous fibrinolysis in a murine model of pulmonary thromboembolism

Published:2021-08 Issue: Volume:204 Page:81-87
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Sansilvestri-Morel Patricia,Rupin Alain,Schaffner Arnaud-Pierre,Bertin Florence,Mennecier Philippe,Lapret Isabelle,Declerck Paul J.,Baumy Philippe,Vallez Marie-Odile,Petit-Dop Florence,Tupinon-Mathieu Isabelle,Delerive Philippe

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association;Mozaffarian;Circulation,2015

2. New insights into the molecular mechanisms of the fibrinolytic system;Rijken;J. Thromb. Haemost.,2009

3. Purification and characterization of TAFI, a thrombin-activatable fibrinolysis inhibitor;Bajzar;J. Biol. Chem.,1995

4. A role for arginine-12 in thrombin–thrombomodulin-mediated activation of thrombin-activatable fibrinolysis inhibitor;Plug;J. Thromb. Haemost.,2014

5. Insights into thrombin activatable fibrinolysis inhibitor function and regulation;Foley;J. Thromb. Haemost.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach;Circulation;2024-09-10

2. Thrombotic Coronary Occlusion and Reperfusion;Journal of the American College of Cardiology;2023-05

3. Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics;International Journal of Molecular Sciences;2021-11-21